Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-κB expression
- 25 January 2010
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 471 (3), 152-156
- https://doi.org/10.1016/j.neulet.2010.01.030
Abstract
Inflammatory processes play a key, mainly detrimental role in the pathophysiology of ischemic stroke. Currently, HMGB1-induced NF-κB activation pathway has been recognized as a key contributor to the proinflammatory response. It has been proved that chronic administration and pre-treatment with statins could protect brain tissue against ischemic injury. However, little is known about the effects of statins in the acute phase after cerebral ischemia. Thus, this study investigated the atorvastatin's protective role and the underlying mechanisms in cerebral ischemia. After middle cerebral artery occlusion (MCAO), atorvastatin was administered immediately. We found that atorvastatin dramatically improved neurological deficits, reduced brain water contents and infarct sizes at 24 h after stroke. Moreover, the over-expression of HMGB1, RAGE, TLR4 and NF-κB induced by ischemia was significantly attenuated by atorvastatin.This publication has 25 references indexed in Scilit:
- Nogo-A Expression After Focal Ischemic Stroke in the Adult RatStroke, 2008
- StrokeThe Lancet, 2008
- Amphoterin as an extracellular regulator of cell motility: from discovery to diseaseJournal of Internal Medicine, 2004
- Antioxidant nutrients and hypoxia/ischemia brain injury in rodentsToxicology, 2003
- Free Radical Pathways in CNS InjuryJournal of Neurotrauma, 2000
- Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic MiceStroke, 2000
- Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cellsLife Sciences, 2000
- Ischemic Cell Death in Brain NeuronsPhysiological Reviews, 1999
- Drug-Induced Neuroprotection From Global Ischemia Is Associated With Prevention of Persistent but Not Transient Activation of Nuclear Factor-κB in RatsStroke, 1998
- Global cerebral ischemia activates nuclear factor-κB prior to evidence of DNA fragmentationMolecular Brain Research, 1997